Results 31 to 40 of about 102,878 (208)

Pancreas transplantation: review [PDF]

Einstein (São Paulo), 2015
ABSTRACT Vascularized pancreas transplantation is the only treatment that establishes normal glucose levels and normalizes glycosylated hemoglobin levels in type 1 diabetic patients. The first vascularized pancreas transplant was performed by William Kelly and Richard Lillehei, to treat a type 1 diabetes patient, in December 1966.
Meirelles Júnior, Roberto Ferreira, Salvalaggio, Paolo, Pacheco-Silva, Alvaro   +2 more
openaire   +5 more sources

Pancreas transplantation today: quo vadis?

European Journal of Endocrinology, 2023
AbstractSuccessful pancreas or islet transplantation is currently the only cure for type 1 diabetes mellitus. Since the first pancreas transplant in 1966, there have been various refinements of surgical technique along with improved immunosuppressive regimens, resulting in significantly improved outcomes, with contemporary research into graft ...
Abdulrahman O Al-Naseem, Ahmed Attia, Ahmed Reda Gonnah, Abdulaziz O A S Al-Naseem, Harry V M Spiers, Angelika Gruessner, Lalantha Leelarathna, Hood Thabit, Titus Augustine   +8 more
openaire   +3 more sources

Pancreas transplantation with isolated splenic artery blood supply – Single center experience

Asian Journal of Surgery, 2020
Summary: Background: The blood supply of the native pancreas by three arterial lines from the celiac trunk system (splenic artery and common hepatic artery) and the superior mesenteric artery forces surgeons to perform vascular reconstruction to provide
Alexey V. Pinchuk, Ilya V. Dmitriev, Yuriy A. Anisimov, Roman V. Storozhev, Aslan G. Balkarov, Aleksandr S. Kondrashkin, Irina V. Khodilina, Rustam Sh Muslimov   +7 more
doaj   +1 more source

Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient: a case report

Korean Journal of Transplantation, 2021
The impact of the coronavirus disease 2019 (COVID-19) vaccination on humoral and cellular immunity in transplant recipients remains unknown. We report the case of a 78-year-old kidney transplant recipient who experienced acute T cell-mediated rejection ...
Hye-Won Jang, Seongman Bae, Youngmin Ko, Seong Jun Lim, Hye Eun Kwon, Joo Hee Jung, Hae yon Cho, Heounjeong Go, Hyunwook Kwon, Young Hoon Kim, Sung-Han Kim, Sung Shin   +11 more
doaj   +1 more source

Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients

Scientific Reports, 2023
Anti-thymocyte globulin (ATG) is currently the most widely prescribed induction regimen for preventing acute rejection after solid organ transplantation. However, the optimal dose of ATG induction regimen in Asian kidney recipients is unclear.
Ye Eun Shim, Youngmin Ko, Jung Pyo Lee, Jin Seok Jeon, Heungman Jun, Jaeseok Yang, Myoung Soo Kim, Seong Jun Lim, Hye Eun Kwon, Joo Hee Jung, Hyunwook Kwon, Young Hoon Kim, Jungbok Lee, Sung Shin, the Korean Organ Transplantation Registry (KOTRY) study group   +14 more
doaj   +1 more source

Incidental Ventricular Septal Defect (VSD) in the Donor of a Live Donor Liver Transplant: Tackle and Proceed [PDF]

Journal of Clinical and Diagnostic Research, 2016
Live Donor Liver Transplantation (LDLT) is an act of selflessness on the part of the donor who is subjected to a major hepatectomy. Ensuring safety and long-term well being of the donor is of utmost priority.
Dinesh Zirpe, Cs Muthukumaran, Anil Vaidya, Anand Ramamurthy   +3 more
doaj   +1 more source

Pancreas transplants

Clinical Radiology, 2009
Cadaveric, whole pancreas transplantation has proved an effective therapy in the treatment of long-standing type 1 diabetes mellitus and is capable of achieving an insulin-independent eugyclaemic state. As a result, this procedure is being increasingly performed. However, the surgical procedure is complex and unfamiliar to many radiologists.
Chandra, J, Phillips, R, Boardman, P, Gleeson, F, Anderson, E   +4 more
openaire   +3 more sources

Quality of life in Type 1 (insulin-dependent) diabetic patients prior to and after pancreas and kidney transplantation in relation to organ function [PDF]

, 1991
Improvement of the quality of life in Type 1 (insulin-dependent) diabetic patients with severe late complications is one of the main goals of pancreas and/or kidney grafting. To assess the influences of these treatment modalities on the different aspects
A Kaplan De-Nour, A. K�nig, BA Bremer, D. Abendroth, DCCT Reaearch Group, DL Patrick, FA Muthny, GH Guyatt, H Troidl, I McDowell, I O'Young, J. Nusser, JL Johnson, JM Najman, LG Hart, LNP Vorugati, LR Derogatis, M Bullinger, M Bullinger, M. Bullinger, MA Andrykowsky, NC Aaronson, R Leighton, R Nakache, R. Landgraf, RJ Corry, RW Evans, S Wood-Dauphinee, S Wood-Dauphinee, S Wood-Dauphinee, SR Walker, W. -D. Illner, W. Land, W. Piehlmeier   +33 more
core   +1 more source

Simultaneous Pancreas-Kidney and Pancreas Transplantation [PDF]

Journal of the American Society of Nephrology, 2001
The discovery of insulin in 1922 changed the treatment of type 1 diabetes mellitus (DM) forever. Insulin was the first effective therapy for type 1 DM; however, its success engendered a terrible paradox for patients with this disease.
Bryan N, Becker, Jon S, Odorico, Yolanda T, Becker, Marilyn, Groshek, Cathy, Werwinski, John D, Pirsch, Hans W, Sollinger   +6 more
openaire   +2 more sources

Assessing causal relationships between iron level, disorders of iron metabolism, and hepatocellular carcinoma: a Mendelian randomisation study

Discover Oncology
Background Emerging evidence indicates that elevated systemic iron levels and dysregulated iron metabolism are closely associated with the pathogenesis of hepatocellular carcinoma (HCC).
Sifan Dong, Xujia Wang, Shiqi An, Yongmei Hu, Junzhi Xiao, An Jiang   +5 more
doaj   +1 more source